These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35385719)

  • 41. Modeling Caco-2 permeability of drugs using immobilized artificial membrane chromatography and physicochemical descriptors.
    Chan EC; Tan WL; Ho PC; Fang LJ
    J Chromatogr A; 2005 Apr; 1072(2):159-68. PubMed ID: 15887485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toward the elucidation of the mechanism for passive membrane permeability of cyclic peptides.
    Riniker S
    Future Med Chem; 2019 Apr; 11(7):637-639. PubMed ID: 30920310
    [No Abstract]   [Full Text] [Related]  

  • 43. Micellar electrokinetic capillary chromatography as a method for determination of n-octanol/water partition coefficients of pesticides.
    Dinelli G; Mallegni R; Vicari A
    Electrophoresis; 1997 Feb; 18(2):214-9. PubMed ID: 9080128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NanoClick: A High Throughput, Target-Agnostic Peptide Cell Permeability Assay.
    Peier A; Ge L; Boyer N; Frost J; Duggal R; Biswas K; Edmondson S; Hermes JD; Yan L; Zimprich C; Sadruddin A; Kristal Kaan HY; Chandramohan A; Brown CJ; Thean D; Lee XE; Yuen TY; Ferrer-Gago FJ; Johannes CW; Lane DP; Sherborne B; Corona C; Robers MB; Sawyer TK; Partridge AW
    ACS Chem Biol; 2021 Feb; 16(2):293-309. PubMed ID: 33539064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationships between octanol-water partition data, chromatographic indices and their dependence on pH in a set of beta-adrenoceptor blocking agents.
    Barbato F; Caliendo G; La Rotonda MI; Morrica P; Silipo C; Vittoria A
    Farmaco; 1990 Jun; 45(6):647-63. PubMed ID: 1980191
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polar interactions drug/phospholipids estimated by IAM-HPLC vs cultured cell line passage data: Their relationships and comparison of their effectiveness in predicting drug human intestinal absorption.
    Grumetto L; Russo G; Barbato F
    Int J Pharm; 2016 Mar; 500(1-2):275-90. PubMed ID: 26780120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improving oral bioavailability of cyclic peptides by N-methylation.
    Räder AFB; Reichart F; Weinmüller M; Kessler H
    Bioorg Med Chem; 2018 Jun; 26(10):2766-2773. PubMed ID: 28886995
    [TBL] [Abstract][Full Text] [Related]  

  • 48. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ.
    Varma MV; Panchagnula R
    J Pharm Sci; 2005 Dec; 94(12):2632-43. PubMed ID: 16258992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
    Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
    J Pharm Sci; 1999 Oct; 88(10):1067-72. PubMed ID: 10514357
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.
    Wohnsland F; Faller B
    J Med Chem; 2001 Mar; 44(6):923-30. PubMed ID: 11300874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bile acid structure-activity relationship: evaluation of bile acid lipophilicity using 1-octanol/water partition coefficient and reverse phase HPLC.
    Roda A; Minutello A; Angellotti MA; Fini A
    J Lipid Res; 1990 Aug; 31(8):1433-43. PubMed ID: 2280184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.
    Winiwarter S; Bonham NM; Ax F; Hallberg A; Lennernäs H; Karlén A
    J Med Chem; 1998 Dec; 41(25):4939-49. PubMed ID: 9836611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immobilized-artificial-membrane chromatography: measurements of membrane partition coefficient and predicting drug membrane permeability.
    Ong S; Liu H; Pidgeon C
    J Chromatogr A; 1996 Mar; 728(1-2):113-28. PubMed ID: 8673230
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Orthogonal chromatographic descriptors for modelling Caco-2 drug permeability.
    Deconinck E; Verstraete T; Van Gyseghem E; Vander Heyden Y; Coomans D
    J Chromatogr Sci; 2012 Mar; 50(3):175-83. PubMed ID: 22337793
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Highly Conformationally Restricted Cyclopropane Tethers with Three-Dimensional Structural Diversity Drastically Enhance the Cell Permeability of Cyclic Peptides.
    Matsui K; Kido Y; Watari R; Kashima Y; Yoshida Y; Shuto S
    Chemistry; 2017 Mar; 23(13):3034-3041. PubMed ID: 27878880
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison between the isocratic and gradient retention behaviour of polypeptides in reversed-phase liquid chromatographic environments.
    Purcell AW; Zhao GL; Aguilar MI; Hearn MT
    J Chromatogr A; 1999 Aug; 852(1):43-57. PubMed ID: 10480229
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers.
    Rezai T; Yu B; Millhauser GL; Jacobson MP; Lokey RS
    J Am Chem Soc; 2006 Mar; 128(8):2510-1. PubMed ID: 16492015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prediction of membrane permeability to peptides from calculated dynamic molecular surface properties.
    Stenberg P; Luthman K; Artursson P
    Pharm Res; 1999 Feb; 16(2):205-12. PubMed ID: 10100304
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A New Amino Acid for Improving Permeability and Solubility in Macrocyclic Peptides through Side Chain-to-Backbone Hydrogen Bonding.
    Taechalertpaisarn J; Ono S; Okada O; Johnstone TC; Lokey RS
    J Med Chem; 2022 Mar; 65(6):5072-5084. PubMed ID: 35275623
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors that restrict the cell permeation of cyclic prodrugs of an opioid peptide, part 4: Characterization of the biopharmaceutical and physicochemical properties of two new cyclic prodrugs designed to be stable to oxidative metabolism by cytochrome P-450 enzymes in the intestinal mucosa.
    Nofsinger R; Borchardt RT
    J Pharm Sci; 2012 Sep; 101(9):3500-10. PubMed ID: 22337204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.